Macquarie Group LTD Inotiv, Inc. Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.27 - $11.04 $2,321 - $7,838	710 New	710 $7,000
Q2 2022 Aug 15, 2022	SELL	$9.56 - $25.91 $10,506 - $28,475	-1,099 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$18.52 - $40.41 $4,778 - $10,425	258 Added 30.68%	1,099 $29,000
Q4 2021 Feb 11, 2022	SELL	$30.55 - $57.88 $15,275 - $28,940	-500 Reduced 37.29%	841 $35,000
Q3 2021 Nov 12, 2021	BUY	$23.69 - $49.93 $31,768 - $66,956	1,341 New	1,341 $39,000

3.78M

1.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $113M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.